as on January 1, 2026 at 2:20 pm IST
Day's Low
Day's High
3.07%
Downside
6.60%
Upside
52 Week's Low
52 Week's High
7.81%
Downside
199.47%
Upside
as on January 1, 2026 at 2:20 pm IST
Market Cap
₹148.34 Cr
Return on Equity (ROE)
2.89
PE Ratio (TTM)
10.26
Return on capital employed (ROCE)
5.06
Industry PE ratio
41.53
Beta (LTM)
0.77
P/B Ratio
2.76
Dividend Yield
0PEG Ratio
-2.48
Quarterly Earnings Growth YOY
-95.42
EPS (TTM)
4.54
Sector
Pharmaceuticals
Book Value
41.98
Technical Analysis
Bearish
View Technical Analysis
as on January 1, 2026 at 2:20 pm IST
Balaxi Pharma in the last 5 years
Lowest (-263.96x)
May 28, 2024
Today (10.26x)
December 31, 2025
Industry (41.53x)
December 31, 2025
Highest (66.45x)
September 21, 2020
Today’s Price to Earnings Ratio: 10.26x
Compare market cap, revenue, PE, and other key metrics of Balaxi Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 148.34 | -15.81% | 0.59 | 25 | 292 | |
| NA | 191.87 | 11.22% | 0.00 | 4 | 473 | |
| NA | 124.60 | 37.37% | 0.00 | 13 | 100 | |
| NA | 807.00 | -8.47% | 0.00 | 47 | 661 | |
| NA | 206.33 | 96.59% | 0.00 | -10 | 109 |
Get share price movements and forecasts by analysts on Balaxi Pharma .
Source: S&P Global Market Intelligence
Search interest for Balaxi Pharmaceuticals Ltd Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Balaxi Pharma .
Balaxi Pharmaceuticals Ltd’s net profit fell -95.42% since last year same period to ₹0.21Cr in the Q2 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -27.59% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2022, Balaxi Pharmaceuticals Ltd has declared dividend of ₹0.50 per share on 23 May 2022 - translating a dividend yield of 1.87%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 25.12% to 30.49% in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 65.99% of holdings in Sep 2025 quarter
Price Dip
![]()
In the last 7 days, BALAXI stock has moved down by -5.4%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 8.87% to 3.50% in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 8.64 Cr → 0.21 Cr (in ₹), with an average decrease of 62.1% per quarter
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 77.23 Cr → 57.76 Cr (in ₹), with an average decrease of 9.1% per quarter
| Organisation | Balaxi Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Ashish Maheshwari |
| E-voting on shares | Click here to vote |
Balaxi Pharma share price today stands at ₹28.05 as on . Balaxi Pharma share today touched a day high of ₹29.9 and a low of ₹27.19.
Balaxi Pharma touched a 52 week high of ₹84 and a 52 week low of ₹25.86. Balaxi Pharma share price today i.e. is trending at ₹28.05, which is -66.61% down from its 52 week high and 8.47% up from its 52 week low.
Balaxi Pharma market capitalisation is ₹148.34 Cr as on .
To buy Balaxi Pharma shares, you need to follow these steps:
Balaxi Pharma trading volume is 3.19L as on . This means that 3.19L shares of Balaxi Pharma were bought and sold on the stock market during today's trading session.